TAG:
ameripath
Physician Solutions Gets Venture Capital Funding
CEO SUMMARY: Physician Solutions becomes the second pathology-based physician practice management company to receive venture capital funding. The company is poised to acquire a number of pathology practices in cities throughout the United States. It is another sign that traditional pathol…
Market Upheavals Around The Corner
In reviewing the galley proofs for this issue of THE DARK REPORT, I am struck by the potential for significant market upheaval in two areas of laboratory medicine: pathology and the clinical laboratory marketplace of California. The stories about AmeriPath, Inc. and California labora…
AmeriPath Successfully Completes Public Offering
CEO SUMMARY: AmeriPath’s new status as a public company gives it even greater visibility than before. As the first public pathology-based physician practice management firm, AmeriPath has the potential to introduce many innovations into the business organization of pathology services. W…
“October 6, 1997 Intelligence: Late Breaking Lab News”
Michael J. Bechich, M.D., Ph.D. at the University of Pittsburgh School of Medicine, is hosting his second annual conference in Pittsburgh next week. Anatomic Pathology Informatics, Imaging and the Internet is scheduled for October 16-18 at the Pittsburgh Marriott City Center…
Pathology PPM Attempts Public Offering Of Shares
CEO SUMMARY: AmeriPath’s efforts to become a public company make it the most visible management experiment in the pathology world today. Already considered controversial by many pathologists, should AmeriPath successfully pull off its proposed initial public stock offering, it will assu…
How AmeriPath Will Alter Pathology Marketplace
CEO SUMMARY: Few pathologists realize how much impact AmeriPath’s business activities will have upon the profession of pathology. Regardless of AmeriPath’s ultimate success or failure, it will bring about irrevocable change to the pathology industry. As the harbinger of such change, A…
Physician Management Companies Exploding, Will Transform Healthcare
CEO SUMMARY: Consolidation and integration of healthcare services will be the dominant trend during the next five years. It happened to commercial laboratories from 1985-95. Widespread hospital consolidation began around 1990 and continues today. Now consolidation is coming to physicians….
AmeriPath Stock Offering Pulled By Underwriters
CEO SUMMARY: Ameripath planned to go public in March. However, the stock market’s significant decline and further evaluation of the company’s business plan caused Wall Street underwriters to defer issuing the stock. Pathologists are curious as to whether AmeriPath’s “employee” b…
Success Seems Elusive To Pathology Innovators
CEO SUMMARY: Attempts to organize pathology practice management companies encounter resistance and market impediments. Success requires an astute business plan and a sophisticated management team to convince pathologists to abandon proven practice models and affiliate with regional or nat…
Plenty Of Money To Go Around
Despite what managed care is doing to clinical laboratories, money abounds to sell more goods. In this issue, you will read about how AmeriPath, Inc. is about to raise $71.7 million while Cytyc Corp. intends to generate $48.2 million in its second public offering in …
CURRENT ISSUE
Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.